Ignite Creation Date:
2024-05-05 @ 12:05 PM
Last Modification Date:
2024-10-26 @ 9:19 AM
Study NCT ID:
NCT00233584
Status:
COMPLETED
Last Update Posted:
2008-01-14
First Post:
2005-10-04
Brief Title:
Pulmicort Asthma Prevention Post-PAC
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Study Overview
Official Title:
A Study to Evaluate the Feasibility of a Treatment Algorithm in Newly Diagnosed Asthmatic Children An Open Follow-up to Asthma Prevention in InfantsYoung Children PAC
Status:
COMPLETED
Status Verified Date:
2008-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This prospective study will evaluate the feasibility of the defined decision tree for the treatment of asthmatic young children Children who develop episode 3 consecutive days of any troublesome lower respiratory symptoms are treated according to a strictly pre-defined multi-steps treatment algorithm until the age of 6 years
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None